# US 11,998,522 B2 · Penetrating topical pain relief compositions and methods of use > Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt - Number: US 11,998,522 B2 - Document ID: US11998522B2 - Status: Granted - Kind: B2 - Application number: 17/884,900 - Filed: 2022-08-10 - Published: 2022-12-15 - Granted: 2024-06-04 - Earliest claimed: 2019-05-28 - Assignees: Tech Swerve LLC - Applicants: Tech Swerve LLC - Inventors: John M. Guynn - Web page: https://patentgrep.com/patent/US11998522B2 ## CPC - A61K 9/0014: {Skin, i.e. galenical aspects of topical compositions (non-active ingredients are additionally classified in A61K47/00; A61K9/0009, A61K9/0021, A61K9/7015, A61K9/7023 take precedence; cosmetic preparations A61K8/00, A61Q; preparations for wound dressings or bandages A61L26/00)} - A61K 31/658: {o-phenolic cannabinoids, e.g. cannabidiol, cannabigerolic acid, cannabichromene or tetrahydrocannabinol} - A61K 9/06: Ointments; Bases therefor; {Other semi-solid forms, e.g. creams, sticks, gels (composition of ointments, creams or gels A61K47/00)} - A61K 9/107: Emulsions {; Emulsion preconcentrates; Micelles (composition of emulsions A61K47/00)} - A61K 31/01: Hydrocarbons - A61K 31/015: carbocyclic - A61K 31/045: Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates - A61K 31/125: Camphor; Nuclear substituted derivatives thereof - A61K 31/35: having six-membered rings with one oxygen as the only ring hetero atom - A61K 31/353: 3,4-Dihydrobenzopyrans, e.g. chroman, catechin - A61K 47/02: Inorganic compounds - A61K 47/10: Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers - A61K 47/20: containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids - A61K 47/44: Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin (synthetic glycerides, e.g. medium-chain triglycerides, A61K47/14) - A61K 47/46: Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts - A61P 29/02: without antiinflammatory effect - A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D) - A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS ## Abstract Topical pain relief compositions include a cannabinoid, terpenoid, and skin penetration system that includes dimethyl sulfoxide (DMSO) and at least one compatibilizer. The composition may be in the form of an emulsion that contains water and at least one fatty component. The composition can be used to reduce or eliminate pain by direct topical application to an affected part or region of the body. A method of treating pain may include direct topical application of the composition to a joint, ligament, muscle, tendon, or disk. The composition penetrates through the skin to provide localized pain relief where applied and provides a quantity of cannabinoid in the region of the pain instead of distributing the cannabinoid systemically and/or to the brain or central nervous system. The composition may be applied by rubbing or massaging at the treatment site and/or by a bandage, patch or other barrier layer. ## Claims ### Claim 1 A method of providing localized pain relief via transdermal delivery of a topical pain relief composition, comprising: identifying an affected region of a body that experiences pain; applying a topical pain relief composition to skin at the affected region and not to the back of the neck at the hairline (BONATH), the topical pain relief composition comprising: at least one cannabinoid; at least one of a fatty component, a terpenoid component, or an essential oil component; a compatibilizer comprising an amphophilic organic compound that includes a hydrocarbon lipophilic portion and a polar hydrophilic portion with one or more heteroatoms (O, N, or S); and at least 20% by weight of dimethyl sulfoxide (DMSO), wherein the composition contains greater than 35% by combined weight of the DMSO and the compatibilizer; and the composition penetrating through the skin at the affected region and reducing or eliminating pain at the affected region. ### Claim 2 (depends on 1) The method of claim 1, wherein the affected region experiences pain that is or is associated with shoulder pain, muscular pain, back pain, joint pain, knee pain, hamstring pain, arm pain, tennis elbow, bunion, ankle pain, foot pain, hand pain, finger joint pain, wrist pain, pinched nerves, degenerated disk, headache, plantar fasciitis, neuromuscular condition, multiple sclerosis, Parkinson's disease, cancer, and combinations thereof. ### Claim 3 (depends on 1) The method of claim 1, wherein the pain is chronic pain. ### Claim 4 (depends on 1) The method of claim 1, wherein the pain is idiopathic pain. ### Claim 5 (depends on 1) The method of claim 1, wherein the composition is applied to the skin at the affected region and covered by a bandage, patch, or other barrier layer. ### Claim 6 (depends on 5) The method of claim 5, wherein the composition is applied by the bandage, patch, or other barrier layer. ### Claim 7 (depends on 1) The method of claim 1, wherein the topical pain relief composition further comprises water. ### Claim 8 (depends on 7) The method of claim 7, wherein the composition is an emulsion. ### Claim 9 (depends on 1) The method of claim 1, wherein the DMSO is included in a range of 20% to about 75% by weight of the topical pain relief composition. ### Claim 10 (depends on 1) The method of claim 1, wherein the DMSO is included in a range of about 25% to about 70% by weight of the topical pain relief composition. ### Claim 11 (depends on 1) The method of claim 1, wherein the composition comprises at least one terpenoid that enhances effectiveness of the at least one cannabinoid. ### Claim 12 A method of providing localized pain relief via transdermal delivery of a topical pain relief composition, comprising: identifying an affected region of a body that experiences pain; applying a topical pain relief composition to skin at the affected region and not to the back of the neck at the hairline (BONATH), the topical pain relief composition comprising: 0.05-10% by weight of at least one of CBD or THC; at least one terpenoid; a skin penetration system comprising dimethyl sulfoxide (DMSO) and a compatibilizer, wherein the topical pain relief composition comprises at least 20% by weight of DSMO; water; and a fatty component, wherein the composition is an emulsion, wherein the composition contains greater than 35% by combined weight of the DMSO, compatibilizer, and water; and the composition penetrating through the skin at the affected region and reducing or eliminating pain at the affected region. ### Claim 13 (depends on 12) The method of claim 12, wherein the composition comprises delta-8 THC. ### Claim 14 (depends on 12) The method of claim 12, the at least one terpenoid including a plurality of terpenoids selected from the group consisting of α-pinene, β-pinene, camphene, β-myrcene, humulene, α-bisabolol, β-caryophyllene, linalool, camphor, limonene, ocimene, α-phellandrene, 1,8-ceneole, eucalyptol, γ-terpinene, terpineol, fenchol, phytol, nerolidol, geranyl acetate, sabinene, p-cymene, β-phellandrene, valencene, borneol, isoborneol, geraniol, δ-3-carene, and terpinolene. ### Claim 15 A method of providing localized pain relief via transdermal delivery of a topical pain relief composition, comprising: identifying an affected region of a body that experiences pain, the affected region being selected from arm, hand, finger, leg, foot, ankle, knee, buttock, back, shoulder, joint, ligament, muscle, tendon, or disk; applying a topical pain relief composition to the affected region and not to the back of the neck at the hairline (BONATH), the composition comprising: a cannabinoid component; 20% to 80% by weight of dimethyl sulfoxide (DMSO); a fatty component; and a compatibilizer, wherein the composition is an emulsion, wherein the composition contains greater than 35% by combined weight of the DMSO, compatibilizer, and water; and the composition penetrating through the skin at the affected region and reducing or eliminating pain at the affected region. ### Claim 16 (depends on 15) The method of claim 15, wherein the cannabinoid component is selected from the group consisting of cannabidiol (CBD), tetrahydrocannabinol (THC), cannabinol (CBN), cannabigerol (CBG), cannabichchromene (CBC), cannabicyclol (CBL), tetrahydrocannabivarin (THCV), cannabidivarin (CBDV), cannabichromevarin (CBCV), cannabigerovarin (CBGV), delta-8-tetrahydrocannabinol, delta-9-tetrahydrocannabinol (Dronabinol), cannabigerol monomethyl ether (CBGM), and nabilone. ### Claim 17 (depends on 16) The method of claim 16, the composition further comprising a terpenoid component selected from the group consisting of α-pinene, β-pinene, camphene, β-myrcene, humulene, α-bisabolol, β-caryophyllene, linalool, camphor, limonene, ocimene, α-phellandrene, 1,8-ceneole, eucalyptol, γ-terpinene, terpineol, fenchol, phytol, nerolidol, geranyl acetate, sabinene, p-cymene, β-phellandrene, valencene, borneol, isoborneol, geraniol, δ-3-carene, and terpinolene. ### Claim 18 (depends on 17) The method of claim 17, wherein the cannabinoid component comprises CBD and/or THC, and the terpenoid component comprises at least two of linalool, α-pinene, β-myrcene, β-caryophyllene, or humulene and/or at least five of β-myrcene, limonene, β-caryophyllene, humulene, linalool, β-pinene, α-pinene, α-bisabolol, terpineol, fenchol, phytol, nerolidol, geranyl acetate, and camphene. ### Claim 19 (depends on 16) The method of claim 16, wherein the compatibilizer is selected from the group consisting of alcohols, polyols, thiols, carboxylic acids, carboxylates, polycarboxylates, esters, amides, ketones, aldehydes, ethers, sulfonates, phosphonates, and amines, and the fatty component is selected from the group consisting of fatty acids, caproic acid, capric acid, caprylic acid, lauric acid, medium chain fatty acid (8 to 10 carbons), stearic acid, isostearic acid, octanoic acid, oleic acid, linoleic acid, linolenic acid, esters of fatty acids, mono-, di- and/or triglycerides of fatty acids, olive oil, sunflower seed oil, coconut oil, cocoa butter, jojoba oil, almond oil, pine needle oil, shea butter, argan oil, nigella sativa oil, beeswax, and flaxseed oil. ### Claim 20 (depends on 12) The method of claim 12, wherein the DMSO is included in a range of about 25% to about 75% by weight of the topical pain relief composition.